Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Pneumococcal | 6 | 2019 | 133 | 1.640 |
Why?
|
| Gelsolin | 3 | 2019 | 189 | 1.240 |
Why?
|
| Macrophages, Alveolar | 7 | 2017 | 415 | 1.040 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2015 | 706 | 0.770 |
Why?
|
| Immunologic Factors | 2 | 2019 | 1594 | 0.410 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.210 |
Why?
|
| Immunity, Innate | 2 | 2014 | 3079 | 0.210 |
Why?
|
| Lung | 5 | 2023 | 10094 | 0.190 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2023 | 271 | 0.180 |
Why?
|
| Phagocytosis | 4 | 2015 | 1530 | 0.180 |
Why?
|
| Receptors, Immunologic | 3 | 2017 | 1418 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 6515 | 0.150 |
Why?
|
| Streptococcus pneumoniae | 3 | 2015 | 764 | 0.140 |
Why?
|
| Receptors, Scavenger | 1 | 2017 | 123 | 0.140 |
Why?
|
| Muromonab-CD3 | 1 | 2016 | 104 | 0.130 |
Why?
|
| Maternal Exposure | 2 | 2017 | 1096 | 0.130 |
Why?
|
| Air Pollutants | 4 | 2017 | 2915 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 780 | 0.120 |
Why?
|
| Francisella tularensis | 1 | 2015 | 60 | 0.120 |
Why?
|
| Indans | 1 | 2014 | 92 | 0.110 |
Why?
|
| Benzodioxoles | 1 | 2014 | 80 | 0.110 |
Why?
|
| Asthma | 3 | 2023 | 6273 | 0.110 |
Why?
|
| Microbial Viability | 1 | 2014 | 237 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 255 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2023 | 1541 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2014 | 557 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 452 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1183 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 822 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 22381 | 0.090 |
Why?
|
| Titanium | 3 | 2007 | 495 | 0.080 |
Why?
|
| Actins | 1 | 2017 | 2064 | 0.080 |
Why?
|
| Mice | 10 | 2023 | 82024 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18344 | 0.080 |
Why?
|
| Astrocytes | 1 | 2016 | 1351 | 0.080 |
Why?
|
| Vehicle Emissions | 2 | 2017 | 651 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 1793 | 0.080 |
Why?
|
| Weight Loss | 1 | 2019 | 2721 | 0.070 |
Why?
|
| Estrogens | 1 | 2014 | 1536 | 0.070 |
Why?
|
| Animals | 12 | 2023 | 169222 | 0.070 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2007 | 112 | 0.070 |
Why?
|
| Neutrophil Activation | 2 | 2007 | 180 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10098 | 0.070 |
Why?
|
| Particulate Matter | 2 | 2007 | 2617 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 454 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 760 | 0.060 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2015 | 4215 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2023 | 115 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 3114 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9666 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 417 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14486 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 455 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15597 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2003 | 704 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2023 | 995 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3159 | 0.040 |
Why?
|
| Antigens | 1 | 2023 | 1442 | 0.040 |
Why?
|
| Inflammation | 2 | 2015 | 10871 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22287 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 267 | 0.030 |
Why?
|
| Male | 6 | 2019 | 364641 | 0.030 |
Why?
|
| HIV Infections | 1 | 2023 | 17569 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2017 | 677 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2017 | 390 | 0.030 |
Why?
|
| Neutrophils | 2 | 2007 | 3786 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10840 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 485 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6231 | 0.030 |
Why?
|
| Inhalation Exposure | 2 | 2007 | 432 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65364 | 0.030 |
Why?
|
| Lung Injury | 1 | 2017 | 433 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4351 | 0.020 |
Why?
|
| Eosinophils | 1 | 2017 | 951 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3703 | 0.020 |
Why?
|
| Particle Size | 2 | 2007 | 1649 | 0.020 |
Why?
|
| Protein Binding | 2 | 2017 | 9343 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 59598 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 60048 | 0.020 |
Why?
|
| Cytokines | 3 | 2007 | 7450 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 89155 | 0.020 |
Why?
|
| Bacteria | 1 | 2017 | 2216 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2745 | 0.020 |
Why?
|
| Female | 5 | 2017 | 397113 | 0.020 |
Why?
|
| Cities | 1 | 2007 | 543 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2007 | 393 | 0.010 |
Why?
|
| Aerosols | 1 | 2007 | 634 | 0.010 |
Why?
|
| Oxidative Stress | 2 | 2007 | 3140 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2004 | 131 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 168 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1760 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4426 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 223583 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 171446 | 0.010 |
Why?
|
| Pregnancy | 2 | 2017 | 30260 | 0.010 |
Why?
|
| Humans | 6 | 2023 | 767991 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 13091 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 223422 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 1340 | 0.010 |
Why?
|
| Metals | 1 | 2003 | 713 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 2149 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3798 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3771 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 1610 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3813 | 0.010 |
Why?
|
| Antioxidants | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7597 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 5772 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3443 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5902 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4525 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12797 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9556 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9536 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11930 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 5799 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9252 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19017 | 0.000 |
Why?
|
| Rats | 1 | 2003 | 23751 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 17128 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40214 | 0.000 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_